查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
鼻咽拭子市场 - 成长、未来前景、竞争分析，2023-2031
市场调查报告书
商品编码
1347826

鼻咽拭子市场 - 成长、未来前景、竞争分析，2023-2031

Nasopharyngeal Swabs Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
出版日期: | 出版商: Acute Market Reports | 英文 115 Pages | 商品交期: 最快1-2个工作天内

价格

预计 2023 年至 2031 年期间，鼻咽拭子市场将以 2.5% 的复合年增长率成长，特别是在 COVID-19 大流行期间诊断测试需求增加的推动下。鼻咽拭子广泛用于采集呼吸道标本，并可检测流感、呼吸道合胞病毒 (RSV) 和引起 COVID-19 的病毒 SARS-CoV-2 等传染病。促进市场成长的主要因素之一是医疗保健专业人员和公众对早期发现疾病的重要性的认识不断提高。鼻咽拭子是诊断测试的首选，因为它们提供了一种非侵入性且可靠的呼吸道检体采集方法。此外，即时检测设施的激增进一步推动了对鼻咽拭子的需求。市场收入大幅成长，主要是由于大流行期间对 COVID-19 检测的空前需求。随着世界各国政府和医疗机构大力投资诊断检测基础设施，鼻咽拭子的使用量激增。此外，持续的研发活动引入了创新的拭子设计，可提高患者舒适度和样本采集效率，进一步推动市场成长。然而，市场并非没有挑战。医疗器材严格的监管要求和不同的地区报销政策可能会抑制鼻咽拭子的成长。此外，替代样本采集方法（例如基于唾液的测试）的出现可能对市场扩张构成潜在威胁。

COVID-19 大流行期间诊断测试的需求增加

COVID-19大流行是鼻咽拭子市场的主要驱动因素。由于需要进行广泛的诊断测试来识别病毒并控制其传播，对鼻咽拭子的需求激增。世界各地的政府和医疗机构在测试基础设施上投入巨资，促进了市场的成长。在大流行期间，许多国家报告称，由于前所未有的需求，鼻咽拭子已经用完。例如，2020年初，美国面临供应短缺，政府采取措施增加拭子的生产和向检测设施的分配。其他地区的类似报告突显了大流行期间对鼻咽拭子的需求激增。

拭子设计的进步可提高病患舒适度和检体采集效率

医疗保健产业的持续研究和开发工作显着改善了鼻咽拭子的设计。这些创新的重点是提高样本采集过程中患者的舒适度，减少手术的侵入性，并提高样本采集效率。医学期刊上发表的研究报告了拭子设计的各种进展。其中包括开发灵活、更柔软、尺寸更小的棉籤，在样本采集过程中不会引起患者不适。研究论文还强调了新拭子设计在收集足够样本以进行准确诊断测试方面的有效性，并强调了持续改进拭子技术的重要性。

提高对早期疾病检测和即时检测设施的认识

医疗保健专业人员和公众对早期疾病检测重要性的认识不断提高，推动了鼻咽拭子的采用。即时检测设施现已广泛使用，使个人更容易快速接受检测并快速获得结果。公共卫生运动、媒体通报和教育活动强调及早发现疾病的重要性。因此，人们变得更愿意接受诊断测试，其中通常包括鼻咽拭子。此外，在诊所、药房和社区中心建立即时检测设施使检测变得更加容易和方便，进一步增加了对鼻咽拭子的需求。

医疗器材严格监管要求

由于对包括拭子在内的医疗器材实施严格的监管要求，鼻咽拭子市场面临重大限制因素。各个地区的监管机构都要求在允许拭子进入市场之前进行严格的测试、安全评估和品质控制措施。这些要求通常会导致製造商的审批时间更长并增加成本。例如，美国食品药物管理局 (FDA) 要求拭子製造商在销售其产品之前遵守上市前通知流程 (510(k)) 或获得上市前批准 (PMA)。同样，欧盟 (EU) 的 CE 标记流程要求进行合格评定并遵守医疗器械的基本健康和安全要求。这些严格的监管障碍可能会推迟产品上市并阻止中小型製造商进入鼻咽拭子市场，从而影响整体市场成长。因此，公司必须投入大量时间和资源来确保遵守监管准则，这可能会阻碍创新并限制市场扩张。着名医学期刊上发表的研究论文和文章讨论了医疗器材製造商在满足鼻咽拭子监管要求方面面临的挑战。这些报告详细介绍了获得监管部门批准所需的复杂流程和大量文件。此外，该案例研究还描述了公司如何因严格的监管要求而在将鼻咽拭子推向市场时面临延误和障碍。

泡棉棉籤在预测期内带来商机

在市场上提供的各种类型的鼻咽拭子中，泡沫尖端拭子预计在 2023 年至 2031 年的预测期内将表现出最高的复合年增长率。泡沫拭子因其在样本采集和患者舒适度方面的卓越性能而越来越受欢迎。柔软、有弹性的泡棉材质可最大限度地减少采样过程中鼻腔不适或受伤的风险，使其受到医疗保健专业人员和患者的青睐。此外，事实证明，泡沫头拭子可以非常有效地收集足够的样本以进行准确的诊断测试，这使得它们在包括COVID-19 在内的各种呼吸道感染中得到越来越多的采用。我是。因此，在 COVID-19 大流行期间，对尖头拭子的需求大幅增加，从而促进了收入的大幅增长。另一方面，非织造拭子的复合年增长率和收入相对较低。儘管无纺棉籤被广泛使用且容易获得，但它们通常被认为不如泡棉头棉籤舒适且效率较低。与不织布拭子相比，人们更喜欢泡沫头拭子，这可以从其在鼻咽拭子市场中更高的采用率和收入证明。最后， "其他" 类别包括除泡沫头和不织布之外的各种类型的鼻咽拭子，但它们占市场份额很小。虽然这个细分市场提供了一个利基选择，但它面临着与泡沫头拭子的卓越性能和可接受性竞争的挑战。总体而言，泡沫头棉籤已成为鼻咽拭子市场中明显的领跑者，由于其卓越的效率、患者舒适度以及COVID-19 大流行期间需求的增加，其复合年增长率最高，体验并产生最高的回报。

医院仍然是主要最终用户

在鼻咽拭子市场的各个最终用户细分市场中，医院预计在 2023-2031 年预测期内呈现最高的复合年增长率，并在 2022 年实现收入。医院是鼻咽拭子的主要消费者，因为它们在呼吸道感染的诊断和治疗中发挥重要作用。随着COVID-19等传染病的迅速增加，医院对鼻咽拭子的需求激增，大大贡献了高额利润。此外，医院建立了医疗基础设施和实验室，可以进行高效、大规模的检测，进一步推动了对鼻咽拭子的需求。儘管诊所也是重要的消费者，但其复合年增长率和收入相对较低。儘管诊所定期进行诊断测试，但测试量可能低于医院。此外，一些诊所选择替代样本采集方法，例如基于唾液的测试，影响了该领域鼻咽拭子的成长。学术和研究机构也是重要的最终用户群体，透过参与科学和临床研究为鼻咽拭子市场做出贡献。儘管研究机构产生的收入可能不如医院和诊所那么多，但由于各种研究和试验对鼻咽拭子的稳定需求，它们拥有稳定的市场份额。最后， "其他" 类别，包括疗养院、家庭医疗保健、工业设施等，与医院、诊所和研究机构相比，其市场份额较小。儘管市场规模较小，但该细分市场仍对整体市场收入做出贡献，反映了鼻咽拭子在不同环境下的多功能性和广泛适用性。总之，在鼻咽拭子市场中，医院的复合年增长率和销售额最高，成为主导的最终用户群。这是由于其在疾病诊断中的重要作用以及市场区隔流行期间需求的增加。

亚太地区仍居世界领先地位

北美成为 2023-2031 年预测期内复合年增长率最高的地区。该地区强大的医疗基础设施、先进诊断技术的广泛采用以及积极的政府举措正在推动对鼻咽拭子的需求。COVID-19 的爆发进一步增加了诊断测试的需求，大大促进了该地区的高复合年增长率。此外，北美是几个积极参与拭子生产和分销的主要市场参与者的所在地，进一步推动了市场的成长。另一方面，亚太地区是2022年鼻咽拭子市场销售占比最高的地区。由于该地区人口众多，尤其是中国和印度等国家，对诊断检测的需求很大，推动了鼻咽拭子的采用。此外，人们越来越认识到早期发现疾病的重要性，以及呼吸道感染盛行率的不断上升，正在推动亚太地区的市场成长。另一个优点是该地区本地生产厂商众多，保证了鼻咽拭子的稳定供应。由于医疗成本上升、疾病负担增加以及先进诊断技术的采用，欧洲以及拉丁美洲和中东等其他地区也推动了鼻咽拭子市场的显着成长。

预测期内市场竞争将加剧

鼻咽拭子市场的主要参与者包括Thermo Fisher Scientific, Inc.、Becton, Dickinson and Company（原CR Bard, Inc.）、Medical Wire & Equipment (MWE)、Titan Biotech Ltd.、COPAN Diagnostics, Inc.，其中包括Miraclean Technology Co. Ltd、Puritan Medical Products、YOCON Biology、Trinity Biotech、VIRCELL SL 和 Quidel Corporation。这些公司以其强大的影响力和对市场的贡献而闻名。为了保持竞争力，这些公司正在实施各种关键举措，包括拭子设计和材料的持续创新、更有效率的全球市场扩张和分销、策略联盟和收购以及遵守严格的监管要求等策略。积极的营销和教育举措也帮助这些公司提高品牌知名度并扩大其整体市场范围。除了以产品为中心的策略外，领先的公司还积极采取积极的营销和教育措施。强调诊断测试的重要性以及鼻咽拭子在疾病早期检测中的作用的宣传活动将提高品牌知名度并有助于整体市场扩张。为了保持竞争优势，这些公司优先考虑遵守严格的监管要求。投资获得监管机构的必要认证和批准可确保产品安全和品质。这不仅体现了对病人安全的承诺，而且还建立了与医疗保健专业人员和最终用户的信任。

目录

第一章 前言

  • 报告内容
    • 报告目的
    • 目标听众
    • 主要提供产品
  • 市场细分
  • 调查方法
    • 第一阶段—二次调查
    • 第二阶段-初步调查
    • 第三阶段-专家评审
    • 先决条件
    • 采取的方法

第二章执行摘要

第三章 鼻咽拭子市场：竞争分析

  • 主要供应商的市场地位
  • 供应商采取的策略
  • 主要产业战略
  • 等级分析：2022 年与 2031 年

第四章鼻咽拭子市场：宏观分析及市场动态

  • 介绍
  • 2021-2031年全球鼻咽拭子市场价值
  • 市场动态
    • 市场驱动力
    • 市场製约因素
    • 主要问题
    • 主要机会
  • 促进因素和抑制因素的影响分析
  • 跷跷板分析

第五章鼻咽拭子市场：依类型2021-2031

  • 市场概况
  • 成长/利润分析：2022 年与 2031 年
  • 市场细分
    • 附泡沫头的棉花棒
    • 不织棉籤
    • 其他

第六章 鼻咽拭子市场：依应用分类 2021-2031

  • 市场概况
  • 成长/利润分析：2022 年与 2031 年
  • 市场细分
    • 流感
    • COVID-19
    • 呼吸道合胞病毒
    • 百日咳博德氏菌感染
    • MRSA（抗甲氧西林金黄色葡萄球菌）
    • 其他

第 7 章 鼻咽拭子市场：依最终使用者分类 2021-2031

  • 市场概况
  • 成长/利润分析：2022 年与 2031 年
  • 市场细分
    • 医院
    • 诊所
    • 学术研究机构
    • 其他

第八章北美鼻咽拭子市场2021-2031

  • 市场概况
  • 鼻咽拭子市场：依类型 2021-2031
  • 鼻咽拭子市场：依应用划分 2021-2031
  • 鼻咽拭子市场：依最终使用者分类 2021-2031
  • 鼻咽拭子市场：按地区 2021-2031
    • 北美
      • 美国
      • 加拿大
      • 其他北美

第9章英国及欧盟鼻咽拭子市场2021-2031

  • 市场概况
  • 鼻咽拭子市场：依类型 2021-2031
  • 鼻咽拭子市场：依应用划分 2021-2031
  • 鼻咽拭子市场：依最终使用者分类 2021-2031
  • 鼻咽拭子市场：按地区 2021-2031
    • 英国和欧盟
      • 英国
      • 德国
      • 西班牙
      • 意大利
      • 法国
      • 欧洲其他地区

第10章亚太鼻咽拭子市场2021-2031

  • 市场概况
  • 鼻咽拭子市场：依类型 2021-2031
  • 鼻咽拭子市场：依应用划分 2021-2031
  • 鼻咽拭子市场：依最终使用者分类 2021-2031
  • 鼻咽拭子市场：按地区 2021-2031
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 亚太其他地区

第十一章拉丁美洲鼻咽拭子市场2021-2031

  • 市场概况
  • 鼻咽拭子市场：依类型 2021-2031
  • 鼻咽拭子市场：依应用划分 2021-2031
  • 鼻咽拭子市场：依最终使用者分类 2021-2031
  • 鼻咽拭子市场：按地区 2021-2031
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 其他拉丁美洲地区

第十二章中东和非洲鼻咽拭子市场2021-2031

  • 市场概况
  • 鼻咽拭子市场：依类型 2021-2031
  • 鼻咽拭子市场：依应用划分 2021-2031
  • 鼻咽拭子市场：依最终使用者分类 2021-2031
  • 鼻咽拭子市场：按地区 2021-2031
    • 中东/非洲
      • 海湾合作委员会
      • 非洲
      • 其他中东/非洲地区

第十三章公司简介

  • Thermo Fisher Scientific Inc.
  • Becton Dickinson and Company（formerly C. R. Bard Inc.）
  • Medical Wire & Equipment（MWE）
  • Titan Biotech Ltd.
  • COPAN Diagnostics Inc.
  • Miraclean Technology Co. Ltd.
  • Puritan Medical Products
  • YOCON Biology
  • Trinity Biotech
  • VIRCELL S.L
  • Quidel Corporation
  • 其他主要公司
Product Code: 139749-08-23

The nasopharyngeal swabs market is expected to grow at a CAGR of 2.5% during the forecast period of 2023 to 2031, driven by the increasing demand for diagnostic testing, particularly during the COVID-19 pandemic. nasopharyngeal swabs are widely used for the collection of respiratory specimens, enabling the detection of infectious diseases, including influenza, respiratory syncytial virus (RSV), and SARS-CoV-2, the virus responsible for COVID-19. One of the key factors contributing to the market's growth is the rising awareness among healthcare professionals and the general public about the importance of early disease detection. nasopharyngeal swabs offer a non-invasive and reliable method to collect respiratory specimens, making them a preferred choice for diagnostic testing. Additionally, the widespread availability of point-of-care testing facilities has further boosted the demand for nasopharyngeal swabs. The market's revenue has witnessed a substantial surge, primarily due to the unprecedented demand for COVID-19 testing during the pandemic. Governments and healthcare organizations across the globe invested heavily in diagnostic testing infrastructure, leading to a surge in the adoption of nasopharyngeal swabs. Moreover, ongoing research and development activities have led to the introduction of innovative swab designs that enhance patient comfort and sample collection efficiency, further driving market growth. However, the market is not without its challenges. Stringent regulatory requirements for medical devices and variations in reimbursement policies across different regions can hinder the growth of nasopharyngeal swabs. Additionally, the emergence of alternative specimen collection methods, such as saliva-based testing, may pose a potential threat to the market's expansion.

Increased Demand for Diagnostic Testing During the COVID-19 Pandemic

The COVID-19 pandemic has been a significant driver of the nasopharyngeal swabs market. The need for widespread diagnostic testing to identify and control the spread of the virus led to a surge in demand for nasopharyngeal swabs. Governments and healthcare organizations worldwide invested heavily in testing infrastructure, contributing to the market's growth. During the pandemic, there were numerous reports of countries experiencing shortages of nasopharyngeal swabs due to unprecedented demand. For instance, in early 2020, the United States faced supply constraints, prompting the government to take measures to increase the production and distribution of swabs to testing facilities. Similar reports emerged from other regions, highlighting the surging demand for nasopharyngeal swabs during the pandemic.

Advancements in Swab Design for Enhanced Patient Comfort and Sample Collection Efficiency

The continuous research and development efforts in the healthcare industry have led to significant improvements in nasopharyngeal swab design. These innovations have focused on increasing patient comfort during sample collection, reducing the invasiveness of the procedure, and improving sample collection efficiency. Published studies in medical journals have reported on various advancements in swab design. These include the development of flexible, softer, and smaller-sized swabs that cause less discomfort to patients during sample collection. Research papers have also highlighted the efficacy of novel swab designs in collecting adequate samples for accurate diagnostic testing, reinforcing the importance of ongoing improvements in swab technology.

Growing Awareness of Early Disease Detection and Point-of-Care Testing Facilities

The increasing awareness among healthcare professionals and the general public about the importance of early disease detection has driven the adoption of nasopharyngeal swabs. Point-of-care testing facilities have become more widely available, making it easier for individuals to get tested quickly and receive prompt results. Public health campaigns, media coverage, and educational initiatives have emphasized the significance of early disease detection. As a result, people are more inclined to undergo diagnostic testing, which often involves nasopharyngeal swabs. Moreover, the establishment of point-of-care testing facilities in clinics, pharmacies, and community centers has made testing more accessible and convenient, further contributing to the demand for nasopharyngeal swabs.

Stringent Regulatory Requirements for Medical Devices

The nasopharyngeal swabs market faces a significant restraint due to the stringent regulatory requirements imposed on medical devices, including swabs. Regulatory authorities across different regions mandate rigorous testing, safety evaluations, and quality control measures before allowing swabs to enter the market. These requirements often lead to longer approval timelines and higher costs for manufacturers. For instance, the U.S. Food and Drug Administration (FDA) requires swab manufacturers to comply with the premarket notification process (510(k)) or obtain premarket approval (PMA) before marketing their products. Similarly, the European Union's CE marking process entails conformity assessments and compliance with essential health and safety requirements for medical devices. These stringent regulatory hurdles can delay product launches and inhibit smaller manufacturers from entering the nasopharyngeal swabs market, impacting overall market growth. As a result, companies must invest significant time and resources to ensure compliance with regulatory guidelines, potentially hindering innovation and restricting market expansion. Published research papers and articles in reputable medical journals discuss the challenges faced by medical device manufacturers in meeting regulatory requirements for nasopharyngeal swabs. These reports detail the complex processes and substantial documentation necessary for obtaining approvals from regulatory authorities. Additionally, case studies highlight instances where companies faced delays and hurdles in introducing nasopharyngeal swabs to the market due to stringent regulatory demands.

Foam-Tipped Swabs to Promise Opportunities During the Forecast Period

Among the different types of nasopharyngeal swabs available in the market, foam-tipped swabs are expected to exhibit the highest CAGR during the forecast period of 2023 to 2031. Foam-tipped swabs are gaining popularity due to their superior performance in sample collection and patient comfort. The soft and flexible foam material minimizes the risk of causing discomfort or injury to the nasal passage during sample collection, making them preferable for both healthcare professionals and patients. Moreover, foam-tipped swabs have demonstrated higher efficiency in collecting an adequate sample for accurate diagnostic testing, leading to increased adoption in various respiratory infections, including COVID-19. As a result, foam-tipped swabs have experienced a significant surge in demand during the COVID-19 pandemic, contributing to their remarkable revenue growth. Non-woven swabs, on the other hand, have shown a comparatively lower CAGR and revenue. Although non-woven swabs are widely used and readily available, they are often perceived to be less comfortable and efficient than foam-tipped swabs. The preference for foam-tipped swabs over non-woven swabs is evident from their higher adoption rates and revenue in the nasopharyngeal swabs market. Lastly, the "Others" category, which includes various types of nasopharyngeal swabs apart from foam-tipped and non-woven, accounts for a smaller portion of the market share. While this segment offers some niche options, it faces challenges in competing with the superior performance and acceptance of foam-tipped swabs. Overall, foam-tipped swabs have emerged as the clear frontrunner in the nasopharyngeal swabs market, experiencing the highest CAGR and generating the highest revenue due to their exceptional efficiency, patient comfort, and increased demand during the COVID-19 pandemic.

Hospitals Remain the Key End Users

Among the various end-user segments in the nasopharyngeal swabs market, hospitals are expected to exhibit the highest CAGR during the forecast period of 2023 to 2031 and revenue generated in 2022. Hospitals are the primary consumers of nasopharyngeal swabs due to their critical role in diagnosing and treating a wide range of respiratory infections. With the surge in infectious diseases like COVID-19, hospitals' demand for nasopharyngeal swabs has skyrocketed, contributing significantly to their high revenue generation. Moreover, hospitals have well-established healthcare infrastructure and laboratories, allowing for efficient and large-scale testing, further boosting the demand for nasopharyngeal swabs. Clinics, although also significant consumers have shown a comparatively lower CAGR and revenue. While clinics regularly perform diagnostic testing, they may have less capacity for testing volume compared to hospitals. Additionally, some clinics may opt for alternative specimen collection methods, such as saliva-based testing, impacting the growth of nasopharyngeal swabs in this segment. Academia & research institutes represent another important end-user segment, contributing to the nasopharyngeal swabs market through their involvement in scientific studies and clinical research. While research institutions may not generate as much revenue as hospitals and clinics, their consistent demand for nasopharyngeal swabs for various studies and trials ensures a stable market share. Lastly, the "Others" category, including settings like nursing homes, home healthcare, and industrial facilities, holds a smaller market share compared to hospitals, clinics, and research institutes. Despite its smaller size, this segment still contributes to the overall market revenue, reflecting the versatility and broad applicability of nasopharyngeal swabs across diverse settings. In conclusion, hospitals stand out as the dominant end-user segment in the nasopharyngeal swabs market, with the highest CAGR and revenue, driven by their crucial role in disease diagnosis and the heightened demand during the COVID-19 pandemic.

APAC remains the Global Leader

North America has emerged as the region with the highest CAGR during the forecast period of 2023 to 2031. The robust healthcare infrastructure, extensive adoption of advanced diagnostic technologies, and proactive government initiatives in the region have fueled the demand for nasopharyngeal swabs. The outbreak of COVID-19 further intensified the need for diagnostic testing, contributing significantly to the region's high CAGR. Additionally, North America houses several key market players actively involved in swab production and distribution, further driving market growth. On the other hand, Asia-Pacific held the distinction of being the region with the highest revenue percentage in the nasopharyngeal swabs market in 2022. The region's large population, especially in countries like China and India, has translated into a substantial demand for diagnostic testing, boosting the adoption of nasopharyngeal swabs. Furthermore, growing awareness of the importance of early disease detection and the increasing prevalence of respiratory infections have driven market growth in Asia-Pacific. The region also benefits from the presence of a significant number of local manufacturers, ensuring a steady supply of nasopharyngeal swabs. Europe and other regions, such as Latin America and the Middle East, have also experienced notable growth in the nasopharyngeal swabs market, driven by increasing healthcare expenditures, rising disease burden, and the adoption of advanced diagnostic technologies.

Market Competition to Intensify during the Forecast Period

Among the top players in the nasopharyngeal swabs market are Thermo Fisher Scientific, Inc., Becton, Dickinson and Company (formerly C. R. Bard, Inc.), Medical Wire & Equipment (MWE), Titan Biotech Ltd., COPAN Diagnostics, Inc., Miraclean Technology Co., Ltd., Puritan Medical Products, YOCON Biology, Trinity Biotech, VIRCELL S.L, and Quidel Corporation. These companies are known for their strong presence and contribution to the market. They employ various key strategies to stay competitive, including continuous innovation in swab designs and materials, global market reach and distribution efficiency, strategic partnerships and acquisitions, and compliance with stringent regulatory requirements. Proactive marketing and educational initiatives also help these companies increase their brand visibility and expand the overall market. In addition to product-focused strategies, top players actively engage in proactive marketing and educational initiatives. Awareness campaigns highlighting the importance of diagnostic testing and the role of nasopharyngeal swabs in early disease detection help increase brand visibility and contribute to overall market expansion. To maintain their competitive advantage, these companies prioritize compliance with stringent regulatory requirements. Investments in obtaining necessary certifications and approvals from regulatory authorities ensure the safety and quality of their products. This not only demonstrates their commitment to patient safety but also builds trust among healthcare professionals and end-users.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofNasopharyngeal Swabs market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Nasopharyngeal Swabs market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Type

  • Foam Tipped Swabs
  • Non-woven Swabs
  • Others

Application

  • Influenza
  • COVID-19
  • Respiratory Syncytial Virus
  • Bordetella Pertussis Infection
  • MRSA (Methicillin-resistant Staphylococcus aureus)
  • Others

End-user

  • Hospitals
  • Clinics
  • Academia & Research Institutes
  • Others

Region Segment (2021-2031; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Nasopharyngeal Swabs market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Nasopharyngeal Swabs market?
  • Which is the largest regional market for Nasopharyngeal Swabs market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Nasopharyngeal Swabs market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Nasopharyngeal Swabs market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Nasopharyngeal Swabs Market
  • 2.2. Global Nasopharyngeal Swabs Market, By Type, 2022 (US$ Million)
  • 2.3. Global Nasopharyngeal Swabs Market, By Application, 2022 (US$ Million)
  • 2.4. Global Nasopharyngeal Swabs Market, By End-user, 2022 (US$ Million)
  • 2.5. Global Nasopharyngeal Swabs Market, By Geography, 2022 (US$ Million)
  • 2.6. Attractive Investment Proposition by Geography, 2022

3. Nasopharyngeal Swabs Market: Competitive Analysis

  • 3.1. Market Positioning of Key Nasopharyngeal Swabs Market Vendors
  • 3.2. Strategies Adopted by Nasopharyngeal Swabs Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. Nasopharyngeal Swabs Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Nasopharyngeal Swabs Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Foam Tipped Swabs
    • 5.3.2. Non-woven Swabs
    • 5.3.3. Others

6. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. Influenza
    • 6.3.2. COVID-19
    • 6.3.3. Respiratory Syncytial Virus
    • 6.3.4. Bordetella Pertussis Infection
    • 6.3.5. MRSA (Methicillin-resistant Staphylococcus aureus)
    • 6.3.6. Others

7. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 7.3. Market Segmentation
    • 7.3.1. Hospitals
    • 7.3.2. Clinics
    • 7.3.3. Academia & Research Institutes
    • 7.3.4. Others

8. North America Nasopharyngeal Swabs Market, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
  • 8.3. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
  • 8.4. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
  • 8.5.Nasopharyngeal Swabs Market: By Region, 2021-2031, USD (Million)
    • 8.5.1.North America
      • 8.5.1.1. U.S.
        • 8.5.1.1.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 8.5.1.1.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 8.5.1.1.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
      • 8.5.1.2. Canada
        • 8.5.1.2.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 8.5.1.2.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 8.5.1.2.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
      • 8.5.1.3. Rest of North America
        • 8.5.1.3.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 8.5.1.3.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 8.5.1.3.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)

9. UK and European Union Nasopharyngeal Swabs Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
  • 9.3. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
  • 9.4. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
  • 9.5.Nasopharyngeal Swabs Market: By Region, 2021-2031, USD (Million)
    • 9.5.1.UK and European Union
      • 9.5.1.1. UK
        • 9.5.1.1.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 9.5.1.1.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.1.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
      • 9.5.1.2. Germany
        • 9.5.1.2.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 9.5.1.2.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.2.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
      • 9.5.1.3. Spain
        • 9.5.1.3.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 9.5.1.3.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.3.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
      • 9.5.1.4. Italy
        • 9.5.1.4.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 9.5.1.4.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.4.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
      • 9.5.1.5. France
        • 9.5.1.5.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 9.5.1.5.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.5.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
      • 9.5.1.6. Rest of Europe
        • 9.5.1.6.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 9.5.1.6.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.6.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)

10. Asia Pacific Nasopharyngeal Swabs Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
  • 10.3. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
  • 10.4. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
  • 10.5.Nasopharyngeal Swabs Market: By Region, 2021-2031, USD (Million)
    • 10.5.1.Asia Pacific
      • 10.5.1.1. China
        • 10.5.1.1.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 10.5.1.1.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.1.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
      • 10.5.1.2. Japan
        • 10.5.1.2.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 10.5.1.2.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.2.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
      • 10.5.1.3. India
        • 10.5.1.3.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 10.5.1.3.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.3.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
      • 10.5.1.4. Australia
        • 10.5.1.4.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 10.5.1.4.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.4.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
      • 10.5.1.5. South Korea
        • 10.5.1.5.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 10.5.1.5.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.5.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
      • 10.5.1.6. Rest of Asia Pacific
        • 10.5.1.6.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 10.5.1.6.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.6.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)

11. Latin America Nasopharyngeal Swabs Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
  • 11.3. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
  • 11.4. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
  • 11.5.Nasopharyngeal Swabs Market: By Region, 2021-2031, USD (Million)
    • 11.5.1.Latin America
      • 11.5.1.1. Brazil
        • 11.5.1.1.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 11.5.1.1.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 11.5.1.1.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
      • 11.5.1.2. Mexico
        • 11.5.1.2.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 11.5.1.2.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 11.5.1.2.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
      • 11.5.1.3. Rest of Latin America
        • 11.5.1.3.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 11.5.1.3.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 11.5.1.3.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)

12. Middle East and Africa Nasopharyngeal Swabs Market, 2021-2031, USD (Million)

  • 12.1. Market Overview
  • 12.2. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
  • 12.3. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
  • 12.4. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
  • 12.5.Nasopharyngeal Swabs Market: By Region, 2021-2031, USD (Million)
    • 12.5.1.Middle East and Africa
      • 12.5.1.1. GCC
        • 12.5.1.1.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 12.5.1.1.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 12.5.1.1.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
      • 12.5.1.2. Africa
        • 12.5.1.2.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 12.5.1.2.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 12.5.1.2.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
      • 12.5.1.3. Rest of Middle East and Africa
        • 12.5.1.3.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 12.5.1.3.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 12.5.1.3.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)

13. Company Profile

  • 13.1. Thermo Fisher Scientific, Inc.
    • 13.1.1. Company Overview
    • 13.1.2. Financial Performance
    • 13.1.3. Product Portfolio
    • 13.1.4. Strategic Initiatives
  • 13.2. Becton, Dickinson and Company (formerly C. R. Bard, Inc.)
    • 13.2.1. Company Overview
    • 13.2.2. Financial Performance
    • 13.2.3. Product Portfolio
    • 13.2.4. Strategic Initiatives
  • 13.3. Medical Wire & Equipment (MWE)
    • 13.3.1. Company Overview
    • 13.3.2. Financial Performance
    • 13.3.3. Product Portfolio
    • 13.3.4. Strategic Initiatives
  • 13.4. Titan Biotech Ltd.
    • 13.4.1. Company Overview
    • 13.4.2. Financial Performance
    • 13.4.3. Product Portfolio
    • 13.4.4. Strategic Initiatives
  • 13.5. COPAN Diagnostics, Inc.
    • 13.5.1. Company Overview
    • 13.5.2. Financial Performance
    • 13.5.3. Product Portfolio
    • 13.5.4. Strategic Initiatives
  • 13.6. Miraclean Technology Co., Ltd.
    • 13.6.1. Company Overview
    • 13.6.2. Financial Performance
    • 13.6.3. Product Portfolio
    • 13.6.4. Strategic Initiatives
  • 13.7. Puritan Medical Products
    • 13.7.1. Company Overview
    • 13.7.2. Financial Performance
    • 13.7.3. Product Portfolio
    • 13.7.4. Strategic Initiatives
  • 13.8. YOCON Biology
    • 13.8.1. Company Overview
    • 13.8.2. Financial Performance
    • 13.8.3. Product Portfolio
    • 13.8.4. Strategic Initiatives
  • 13.9. Trinity Biotech
    • 13.9.1. Company Overview
    • 13.9.2. Financial Performance
    • 13.9.3. Product Portfolio
    • 13.9.4. Strategic Initiatives
  • 13.10. VIRCELL S.L
    • 13.10.1. Company Overview
    • 13.10.2. Financial Performance
    • 13.10.3. Product Portfolio
    • 13.10.4. Strategic Initiatives
  • 13.11. Quidel Corporation
    • 13.11.1. Company Overview
    • 13.11.2. Financial Performance
    • 13.11.3. Product Portfolio
    • 13.11.4. Strategic Initiatives
  • 13.12. Other Notable Players
    • 13.12.1. Company Overview
    • 13.12.2. Financial Performance
    • 13.12.3. Product Portfolio
    • 13.12.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 2 Global Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 3 Global Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 4 North America Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 5 North America Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 6 North America Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 7 U.S. Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 8 U.S. Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 9 U.S. Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 10 Canada Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 11 Canada Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 12 Canada Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 13 Rest of North America Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 14 Rest of North America Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 15 Rest of North America Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 16 UK and European Union Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 17 UK and European Union Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 18 UK and European Union Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 19 UK Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 20 UK Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 21 UK Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 22 Germany Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 23 Germany Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 24 Germany Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 25 Spain Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 26 Spain Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 27 Spain Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 28 Italy Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 29 Italy Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 30 Italy Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 31 France Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 32 France Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 33 France Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 34 Rest of Europe Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 35 Rest of Europe Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 36 Rest of Europe Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 37 Asia Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 38 Asia Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 39 Asia Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 40 China Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 41 China Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 42 China Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 43 Japan Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 44 Japan Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 45 Japan Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 46 India Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 47 India Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 48 India Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 49 Australia Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 50 Australia Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 51 Australia Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 52 South Korea Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 53 South Korea Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 54 South Korea Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 55 Latin America Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 56 Latin America Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 57 Latin America Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 58 Brazil Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 59 Brazil Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 60 Brazil Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 61 Mexico Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 62 Mexico Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 63 Mexico Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 64 Rest of Latin America Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 65 Rest of Latin America Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 66 Rest of Latin America Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 67 Middle East and Africa Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 68 Middle East and Africa Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 69 Middle East and Africa Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 70 GCC Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 71 GCC Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 72 GCC Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 73 Africa Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 74 Africa Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 75 Africa Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 76 Rest of Middle East and Africa Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 77 Rest of Middle East and Africa Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 78 Rest of Middle East and Africa Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)

List of Figures

  • FIG. 1 Global Nasopharyngeal Swabs Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Nasopharyngeal Swabs Market: Quality Assurance
  • FIG. 5 Global Nasopharyngeal Swabs Market, By Type, 2022
  • FIG. 6 Global Nasopharyngeal Swabs Market, By Application, 2022
  • FIG. 7 Global Nasopharyngeal Swabs Market, By End-user, 2022
  • FIG. 8 Global Nasopharyngeal Swabs Market, By Geography, 2022
  • FIG. 9 Market Geographical Opportunity Matrix - Global Nasopharyngeal Swabs Market, 2022

FIG. 10Market Positioning of Key Nasopharyngeal Swabs Market Players, 2022

FIG. 11Global Nasopharyngeal Swabs Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031

  • FIG. 12 Global Nasopharyngeal Swabs Market, By Type, 2022 Vs 2031, %
  • FIG. 13 Global Nasopharyngeal Swabs Market, By Application, 2022 Vs 2031, %
  • FIG. 14 Global Nasopharyngeal Swabs Market, By End-user, 2022 Vs 2031, %
  • FIG. 15 U.S. Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
  • FIG. 16 Canada Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
  • FIG. 17 Rest of North America Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
  • FIG. 18 UK Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
  • FIG. 19 Germany Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
  • FIG. 20 Spain Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
  • FIG. 21 Italy Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
  • FIG. 22 France Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
  • FIG. 23 Rest of Europe Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
  • FIG. 24 China Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
  • FIG. 25 Japan Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
  • FIG. 26 India Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
  • FIG. 27 Australia Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
  • FIG. 28 South Korea Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
  • FIG. 29 Rest of Asia Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
  • FIG. 30 Brazil Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
  • FIG. 31 Mexico Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
  • FIG. 32 Rest of Latin America Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
  • FIG. 33 GCC Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
  • FIG. 34 Africa Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
  • FIG. 35 Rest of Middle East and Africa Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031